ROYAL BANK OF CANADA - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 134 filers reported holding IMMUNITYBIO INC in Q3 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$143,000
+3.6%
84,519
+69.1%
0.00%
Q2 2023$138,000
+68.3%
49,988
+10.0%
0.00%
Q1 2023$82,000
-91.3%
45,436
-75.5%
0.00%
Q4 2022$941,000
+352.4%
185,551
+344.9%
0.00%
Q3 2022$208,000
+15.6%
41,707
-13.4%
0.00%
Q2 2022$180,000
-41.6%
48,187
-11.9%
0.00%
Q1 2022$308,000
-26.5%
54,693
-20.7%
0.00%
Q4 2021$419,000
-15.5%
68,986
+35.6%
0.00%
Q3 2021$496,000
-24.6%
50,890
+10.5%
0.00%
Q2 2021$658,000
-33.1%
46,035
+11.2%
0.00%
Q1 2021$983,00041,3820.00%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders